ARTICLE | Distillery Therapeutics


November 6, 2018 8:46 PM UTC

In silico, in vitro, cell culture and mouse studies identified a positive allosteric modulator (PAM) of SIRT6 that could help treat hepatocellular carcinoma (HCC). In silico screening of a small molec...

BCIQ Company Profiles

Shanghai Jiao Tong University

BCIQ Target Profiles

Sirtuin 6 (SIRT6)